Pancreatic cancer is one of those Step 1 topics that shows up in deceptively simple vignettes—painless jaundice, weight loss, a smoker with new-onset diabetes, or migratory thrombophlebitis—and you’re expected to instantly localize the tumor, name the risk factor, and predict the next diagnostic step. This post is your high-yield, mechanism-first roadmap to mastering it.
Quick Definition (Step-Style)
Pancreatic cancer usually refers to pancreatic ductal adenocarcinoma (PDAC)—a malignant tumor arising from the exocrine ducts of the pancreas.
- Most common type: Ductal adenocarcinoma
- Typical location: Head of the pancreas (clinically important because of biliary obstruction)
- Big picture: late presentation → early metastasis → poor prognosis
First Aid cross-reference: GI Pathology → Pancreas → Pancreatic carcinoma (check the Pancreas section + cancer risk factors pages in your edition)
High-Yield Anatomy: Why “Head” Tumors Cause Jaundice
The common bile duct runs through/adjacent to the head of the pancreas before entering the duodenum. So a mass in the pancreatic head can compress the bile duct → extrahepatic (obstructive) cholestasis.
Classic consequence
- Painless jaundice + dark urine + pale stools + pruritus
- Palpable, nontender gallbladder from back-up (Courvoisier sign)
Pathophysiology (What Step 1 Actually Tests)
Cell of origin + precursor lesions
Pancreatic ductal adenocarcinoma often arises from PanIN lesions (pancreatic intraepithelial neoplasia) via stepwise genetic hits.
Key molecular associations (high yield)
A classic progression you’ll see tested:
| Gene | Role | HY association |
|---|---|---|
| KRAS | Oncogene (signal transduction) | Early event; promotes proliferation |
| CDKN2A (p16) | Tumor suppressor (cell cycle brake) | Loss → unchecked G1→S |
| TP53 | Tumor suppressor (DNA damage response) | Late event; genomic instability |
| SMAD4 (DPC4) | TGF-β signaling tumor suppression | Loss → growth disinhibition |
First Aid cross-reference: General Path → Oncogenes & Tumor Suppressor Genes + GI Path → Pancreas
Tumor markers (board-appropriate nuance)
- CA 19-9: often elevated in pancreatic adenocarcinoma
- Useful for tracking response/recurrence, not a screening test (imperfect sensitivity/specificity)
- Can be falsely low in patients who are Lewis antigen negative (rare but classically testable)
Risk Factors & Associations (Memorize These)
Major risk factors (HY)
- Smoking (biggest modifiable risk factor)
- Chronic pancreatitis (especially alcohol-related or hereditary)
- Age (older adults)
- Diabetes mellitus (new-onset or worsening—can be a clue and sometimes a consequence)
- Obesity
Genetic syndromes (Step favorites)
- BRCA2 mutation → increased pancreatic cancer risk
- Peutz-Jeghers syndrome (STK11) → increased pancreatic cancer risk (and other GI malignancies)
- Hereditary pancreatitis (PRSS1) → increased risk over time
First Aid cross-reference: GI Path → Pancreas + Genetics → Cancer syndromes
Clinical Presentation: Classic Vignette Patterns
1) Tumor in the head: obstructive jaundice picture
- Painless jaundice
- Pruritus
- Dark urine (conjugated bilirubin is water-soluble)
- Clay-colored stools
- Palpable gallbladder (Courvoisier sign)
- Weight loss, anorexia
2) Tumor in body/tail: “silent until late”
- Less likely to cause jaundice early
- Presents with:
- Abdominal/back pain
- Weight loss
- Early metastasis signs
3) Paraneoplastic/hypercoagulable clues
- Trousseau syndrome: migratory superficial thrombophlebitis (hypercoagulable state)
- Unprovoked DVT/PE in an older patient → think malignancy
4) New-onset diabetes in an older adult
- Especially with weight loss and smoking history
- Pancreatic cancer can impair endocrine function or drive systemic inflammation/insulin resistance
Diagnosis (Step 1 + Step 2 Workflow)
Labs: cholestatic pattern if obstructing bile duct
- ↑ Direct (conjugated) bilirubin
- ↑ ALP, ↑ GGT
- Mild ↑ AST/ALT possible
Imaging: what’s typically “next best”
- Contrast-enhanced CT (pancreatic protocol) is commonly used for detection and staging.
- Ultrasound may be used early in jaundice workups to detect biliary dilation, but CT is key for pancreas detail.
- Endoscopic ultrasound (EUS) with biopsy is often used for tissue diagnosis.
ERCP: when it matters
- Can help with biliary decompression/stenting in obstructive jaundice
- May be used diagnostically, but often thought of as therapeutic in modern algorithms
Gross & Histology (Board-Recognizable)
Gross findings
- Firm, ill-defined mass, often in head of pancreas
- Can cause biliary obstruction
Histology
- Adenocarcinoma with glandular structures
- Desmoplastic stroma (dense fibrous tissue reaction—classically mentioned)
First Aid cross-reference: GI Path → Pancreas (histology clues)
Treatment (What You Need for Boards)
Curative intent (if localized and resectable)
- Surgical resection
- Whipple procedure (pancreaticoduodenectomy) for tumors in the head
- Often combined with adjuvant chemotherapy (and sometimes radiation depending on case)
Unresectable/metastatic disease
- Systemic chemotherapy (regimens vary)
- Palliation
- Biliary stenting to relieve jaundice/pruritus
- Pain management, nutritional support
Prognosis (know the headline)
- Overall poor because most cases present late.
- If you see “painless jaundice + weight loss” on a test, assume malignancy until proven otherwise.
High-Yield Differentials (Don’t Get Tricked)
| Condition | Key clue | How it differs from pancreatic adenocarcinoma |
|---|---|---|
| Chronic pancreatitis | Recurrent epigastric pain, calcifications, malabsorption | Pain often longstanding; not typically painless jaundice |
| Pancreatic neuroendocrine tumor (e.g., insulinoma, gastrinoma) | Hormone symptoms (hypoglycemia, refractory ulcers) | Different cell origin; different syndromic associations (MEN1) |
| Cholangiocarcinoma | Biliary tree primary tumor | May present similarly with obstructive jaundice; location differs |
| Gallstone obstruction | Colicky RUQ pain, transient obstruction | Painful; often episodic; stones on imaging |
| Pancreatic pseudocyst | After pancreatitis; elevated amylase; cystic lesion | Post-inflammatory, not malignant; mass effect possible but context is key |
HY “If You See This, Think Pancreatic Cancer” Associations
Ultra-classic cues
- Painless jaundice + palpable gallbladder → tumor in head
- Migratory thrombophlebitis (Trousseau) → mucin-producing adenocarcinoma (pancreas is a classic)
- Smoker + weight loss + epigastric pain radiating to back
- New-onset diabetes in an older adult with systemic symptoms
Biochem tie-in
- Obstructive jaundice → conjugated hyperbilirubinemia → dark urine, pale stool, ↑ALP/↑GGT
Rapid Review Table (Last-Minute Step 1 Crunch)
| Category | Must-know facts |
|---|---|
| Most common type | Pancreatic ductal adenocarcinoma |
| Most common location | Head of pancreas |
| Key presentation | Painless jaundice, weight loss |
| Major risk factor | Smoking |
| Genetics | KRAS, p16, TP53, SMAD4 |
| Marker | CA 19-9 (monitoring, not screening) |
| Hypercoagulability | Trousseau syndrome |
| Diagnosis | CT (pancreatic protocol), EUS biopsy |
| Treatment | Whipple if resectable; chemo/palliation if not |
| Prognosis | Poor (late detection) |
First Aid Cross-Reference Checklist (Use This to Anchor Your Review)
When you’re flipping through First Aid, make sure you can connect pancreatic cancer to:
- Obstructive jaundice physiology (bilirubin handling, cholestasis labs)
- Oncogene/tumor suppressor gene list (KRAS, p53, p16, SMAD4)
- Cancer-associated thrombosis (Trousseau)
- Chronic pancreatitis complications (increased cancer risk)
- CA 19-9 clinical use (trend marker)